Advisor Group Holdings, Inc. Ardelyx, Inc. Transaction History
Advisor Group Holdings, Inc.
- $42.1 Billion
- Q1 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Ardelyx, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 13,145 shares of ARDX stock, worth $52,054. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,145
Previous 8,209
60.13%
Holding current value
$52,054
Previous $42,000
52.38%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding ARDX
# of Institutions
235Shares Held
166MCall Options Held
490KPut Options Held
2.35M-
Janus Henderson Group PLC London, X025MShares$98.9 Million0.07% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$69.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15MShares$59.4 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C311.2MShares$44.2 Million0.07% of portfolio
-
State Street Corp Boston, MA10.2MShares$40.3 Million0.0% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $612M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...